BioCentury
ARTICLE | Clinical News

AMT-060: Phase I/II data

January 11, 2016 8:00 AM UTC

Top-line data from 2 adult hemophilia B patients in the low-dose cohort of an open-label, European Phase I/II trial showed that a single IV infusion of 5x10 12 gc/kg AMT-060 led to confirmed Factor IX...